Related references
Note: Only part of the references are listed.Discovery of Ledipasvir (GS-5885): A Potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus Infection
John O. Link et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Preclinical Characterization of GS-9669, a Thumb Site II Inhibitor of the Hepatitis C Virus NS5B Polymerase
Martijn Fenaux et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
In vitro efficacy of approved and experimental antivirals against novel genotype 3 hepatitis C virus subgenomic replicons
Mei Yu et al.
ANTIVIRAL RESEARCH (2013)
Replication of Hepatitis C Virus Genotype 3a in Cultured Cells
Mohsan Saeed et al.
GASTROENTEROLOGY (2013)
Development of Robust Hepatitis C Virus Genotype 4 Subgenomic Replicons
Betty Peng et al.
GASTROENTEROLOGY (2013)
Update on the Management and Treatment of Hepatitis C Virus Infection: Recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program Office
Helen S. Yee et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Efficient Replication of Genotype 3a and 4a Hepatitis C Virus Replicons in Human Hepatoma Cells
Mohsan Saeed et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Discovery of GS-9451: An acid inhibitor of the hepatitis C virus NS3/4A protease
X. Christopher Sheng et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Hepatitis C Virus in Vietnam: High Prevalence of Infection in Dialysis and Multi-Transfused Patients Involving Diverse and Novel Virus Variants
Linda Dunford et al.
PLOS ONE (2012)
Systematic review: epidemiology of hepatitis C genotype 6 and its management
D. T. Chao et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Mechanistic Characterization of GS-9190 (Tegobuvir), a Novel Nonnucleoside Inhibitor of Hepatitis C Virus NS5B Polymerase
I-hung Shih et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Selection of Clinically Relevant Protease Inhibitor-Resistant Viruses Using the Genotype 2a Hepatitis C Virus Infection System
Guofeng Cheng et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Evolving epidemiology of hepatitis C virus
D. Lavanchy
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Recombinant HCV Variants With NS5A From Genotypes 1-7 Have Different Sensitivities to an NS5A Inhibitor but Not Interferon-α
Troels K. H. Scheel et al.
GASTROENTEROLOGY (2011)
Hepatitis C Virus Genotypes in Clinical Specimens Tested at a National Reference Testing Laboratory in the United States
Jeffrey J. Germer et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt
William Sievert et al.
LIVER INTERNATIONAL (2011)
The global health burden of hepatitis C virus infection
Francesco Negro et al.
LIVER INTERNATIONAL (2011)
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel
Markus Cornberg et al.
LIVER INTERNATIONAL (2011)
Novel Hepatitis C Virus Reporter Replicon Cell Lines Enable Efficient Antiviral Screening against Genotype 1a
Margaret Robinson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Risk factors, genotype 6 prevalence, and clinical characteristics of chronic hepatitis C in Southeast Asian Americans
Nghia H. Nguyen et al.
HEPATOLOGY INTERNATIONAL (2010)
Discovery of a β-D-2′-Deoxy-2′-α-fluoro-2′-β-C-methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus
Michael J. Sofia et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Diagnosis, Management, and Treatment of Hepatitis C: An Update
Marc G. Ghany et al.
HEPATOLOGY (2009)
Development of intergenotypic chimeric replicons to determine the broad-spectrum antiviral activities of hepatitis C virus polymerase inhibitors
Koleen J. Herlihy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Chronic hepatitis C virus genotype 6 infection: Response to pegylated interferon and ribavirin
James Fung et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
The hepatitis C virus replicon system: From basic research to clinical application
R Bartenschlager
JOURNAL OF HEPATOLOGY (2005)
Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I
R Stumper et al.
JOURNAL OF VIROLOGY (2005)
Kissing-loop interaction in the 3 ' end of the hepatitis C virus genome essential for RNA replication
P Friebe et al.
JOURNAL OF VIROLOGY (2005)
Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon
T Kato et al.
GASTROENTEROLOGY (2003)
Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture
KJ Blight et al.
JOURNAL OF VIROLOGY (2003)
Viral and cellular determinants of hepatitis C virus RNA replication in cell culture
V Lohmann et al.
JOURNAL OF VIROLOGY (2003)
Sequences in the 5′ nontranslated region of hepatitis C virus required for RNA replication
P Friebe et al.
JOURNAL OF VIROLOGY (2001)
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
MP Manns et al.
LANCET (2001)
Efficient initiation of HCV RNA replication in cell culture
KJ Blight et al.
SCIENCE (2000)
Share Paper
